Backgound video

MenB Vaccination & Gonorrhoea Prevention

The MenB vaccine was originally developed to prevent meningococcal disease, but evidence suggests it may also provide partial protection against gonorrhoea.

Understanding MenB Vaccination

The meningococcal B (MenB) vaccine was originally developed to protect against invasive meningococcal disease, a rare but potentially life-threatening infection that can cause meningitis and septicaemia.

In recent years, researchers have identified an additional and unexpected benefit. Evidence suggests that MenB vaccination may also provide partial protection against gonorrhoea, one of the most common sexually transmitted infections worldwide.

As rates of gonorrhoea continue to rise and antibiotic resistance becomes an increasing concern, interest in MenB vaccination as a preventative sexual health intervention has grown substantially.

What Is Gonorrhoea?

Gonorrhoea is a bacterial sexually transmitted infection caused by Neisseria gonorrhoeae.

It can affect the urethra, cervix, rectum and throat and may cause symptoms such as:

  • Pain or burning when passing urine
  • Urethral or vaginal discharge
  • Rectal discomfort or discharge
  • Sore throat

However, many infections cause no symptoms at all.

If left untreated, gonorrhoea can lead to complications including pelvic inflammatory disease, infertility, epididymitis and, occasionally, disseminated infection affecting other parts of the body.

Why Might A Meningitis Vaccine Help Prevent Gonorrhoea?

The bacteria responsible for gonorrhoea (Neisseria gonorrhoeae) are closely related to the bacteria responsible for meningococcal disease (Neisseria meningitidis).

Because of these similarities, researchers observed that individuals who had received meningococcal B vaccines appeared to develop lower rates of gonorrhoea than expected.

Subsequent studies have supported this observation, suggesting that MenB vaccination may provide meaningful, although incomplete, protection against gonorrhoea infection.

How Effective Is It?

Unlike HPV vaccination, MenB vaccination was not specifically designed to prevent gonorrhoea and does not provide complete protection.

Current evidence suggests a reduction in gonorrhoea risk of approximately 30–40%, although estimates vary between studies and populations.

This means the vaccine should be viewed as an additional preventative measure rather than a replacement for regular STI screening, condom use or other sexual health strategies.

Nevertheless, even partial protection may become increasingly valuable as antibiotic-resistant gonorrhoea becomes more common worldwide.

Who Might Consider MenB Vaccination?

MenB vaccination may be particularly relevant for:

  • Men who have sex with men
  • Individuals with multiple sexual partners
  • Those with a history of recurrent gonorrhoea
  • Individuals seeking to reduce future STI risk
  • Patients interested in evidence-based preventative sexual health interventions

The decision to vaccinate should always be individualised and considered within the context of a broader sexual health strategy.

What Is The Vaccination Schedule?

Most adults receive a two-dose course administered several weeks apart.

Recommendations may evolve as additional evidence emerges regarding gonorrhoea prevention and national vaccination policies continue to develop.

Is The Vaccine Safe?

MenB vaccines have been used extensively worldwide and have a well-established safety record.

Most side effects are mild and temporary and may include:

  • Arm soreness
  • Fatigue
  • Headache
  • Muscle aches
  • Mild fever

Serious side effects are uncommon.

Our Approach

At The Wright Practice, we take a preventative and evidence-based approach to sexual health. We discuss MenB vaccination within the context of overall STI risk, screening practices and other preventative strategies such as PrEP, PEP, Doxy-PEP and HPV vaccination.

As evidence continues to evolve, MenB vaccination represents an increasingly interesting option for selected individuals seeking to reduce their future risk of gonorrhoea.

Key Points

  • MenB vaccination was originally developed to prevent meningococcal disease.
  • Research suggests it may also provide partial protection against gonorrhoea.
  • Protection is incomplete but may reduce infection risk by approximately 30–40%.
  • Interest has increased because of rising rates of gonorrhoea and antibiotic resistance.
  • MenB vaccination should be viewed as one component of a broader sexual health prevention strategy.
  • The vaccine has a strong safety record and extensive real-world experience.

Meet our team

Dr Daniel Wright
MD MRCGP MA (Hons) BA (Hons)
Dr. Susan Jain
MD MRCGP MA (Hons) BA (Hons)
Nathan Hunt
Practice Manager

What our patients say on Google

Wow! Dr. Dan was extremely knowledgeable and attentive to my health and well being. I’m so glad to have found him!

John Rutherford
John Rutherford

I have been going to Dr Wright for a number of years now. He is highly knowledgeable, compassionate, open minded and efficient, I couldn’t recommend him highly enough

Peter Jones
Peter Jones

I have been a patient of Doctor Dan for some time and continue to consult with him despite having left the UK. Dan has the enthusiasm and energy of a young man, whilst taking the holistic “physician” approach of an old school family doctor, equipped with the most modern insights and technology.

Steve Smith
Steve Smith

Dr Jain was great. Expert knowledge with practical advice

George Mosley
George Mosley

Book Online

Schedule a consultation | Call: +44 (0)207 139 1833 | Email: info@thewrightpractice.com

101 Harley Street, London, W1G 6AH

The Wright Practice

101 Harley Street, London, W1G 6AH, United Kingdom

Rated ★ ★ ★ ★ ★ from 192 Reviews

Opening hours
Monday
9.00 - 17.00
Tuesday
9.00 - 17.00
Wednesday
9.00 - 17.00
Thursday
9.00 - 17.00
Friday
9.00 - 17.00
Saturday
9.00 - 17.00
Sunday
Closed
The Wright Practice
101 Harley Street, London, W1G 6AH, United Kingdom
Get directions
Book Online
Whatsapp